Tristel (TSTL)

 

TSTL Share PerformanceMore

52 week high212.00 20/03/17
52 week low87.00 08/07/16
52 week change 77.00 (65.81%)
4 week volume1,926,377 01/03/17

Media for (TSTL)

Presenter: Paul Swinney
28/02/2017

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Issue of Equity

RNS Number: 7365Y Tristel PLC 07 March 2017 Tristel plc ("Tristel" or "the Company") Issue of Equity Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that on 6 March 2017, 10,000 ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") were issued and allotted pu...

Issue of Equity

RNS Number: 5483Y Tristel PLC 06 March 2017 Tristel plc ("Tristel" or "the Company") Issue of Equity Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that on 3March 2017, 33,000 ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") were issued and allotted pu...

Tristel - Final Results 2016

Tristel says products approved by Australia's TGA

Tristel says its Fuse disinfectant used in its Stella decontamination tray has been approved as a high-level disinfectant by A...

Tristel says products approved by Australia's TGA

Products approved by Australia's TGA

RNS Number: 8584X Tristel PLC 27 February 2017 Tristel plc ("Tristel" or the "Company") Fuse for Stella products approved by Australia's Therapeutic Goods Association Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that its Fuse disinfectant used in its Stella decontamination tray has been...

Journal of Ultrasound in Medicine & Biology

RNS Number: 8492X Tristel PLC 27 February 2017 Tristel plc ("Tristel" or the "Company") Tristel's Wipes and foam disinfectants included in Journal of Ultrasound in Medicine & Biology Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that the World Federation for Ultrasound in Medicine...

Broker Forecast - finnCap issues a broker note on Tristel PLC

finnCap today reaffirms its corporate investment rating on Tristel PLC (LON:TSTL) and raised its price target to 165p (fro...

Fundamental DataMore

P/E ratio38.723
EPS5.01
Dividend yield1.716 %

Equity Research (TSTL)

equity development
Tristel Plc
23/02/2017
Tristel develops proprietary infection, hygiene and contamination control products used by organisations involved in: Human Healthcare (branded Tristel, 85% of sales); Contamination Control (Crystel...
equity development
Tristel Plc
15/12/2016
Tristel develops proprietary infection, hygiene and contamination control products used by: Human Healthcare (branded Tristel, 85% of sales); Contamination Control (Crystel, 9%), and Animal Care (...
equity development
Tristel Plc
19/10/2016
Tristel develops proprietary infection, hygiene and contamination control products used by: Human Healthcare (branded Tristel, 85% of sales); Contamination Control (Crystel, 9%); and Animal care (...

Latest discussion posts More

  • Re: SP

    Thanks for your view TS, I was worried something could have gone awry in US, but absence of big trades now seems reassuring and hopefully more likely indicates settling at new ...
    23-Mar-2017
    Kuznetsov
  • Re: SP

    Just technical IMHO. V strong run recently, probably overbought. Shares characteristically fall quite heavily between news or results. Market makers working to stimulate ...
    22-Mar-2017
    TOFFEESAINT
  • SP

    Any informed opinion about this mornings 11% share price dive would be greatly appreciated. Thanks KUZ
    22-Mar-2017
    Kuznetsov

Users' HoldingsMore

Users who hold Tristel also hold..
LLOYDS GRP.26%
NATIONAL GRID21%
GLAXOSMITHKLINE17%
BARCLAYS15%
VODAFONE GRP.15%

Codes & Symbols

ISINGB00B07RVT99
SymbolsTSTL, LSE:TSTL, TSTL.L, TSTL:LN, LON:TSTL, XLON:TSTL